Table 2 Treatment outcomes of different groups according to Hb level
Variables | Overall survival | LMFS | |||
|---|---|---|---|---|---|
Patient | 5-year OS(%) | P | 5-year LMFS | P | |
Pretreatment Hb | |||||
Anaemia | 39 | 61.5 | 0.40 | 58.4 | 0.59 |
No anaemia | 94 | 58.3 | 53.7 | ||
Neoadjuvant Hb | |||||
Anaemia | 99 | 57.9 | 0.11 | 51.8 | 0.14 |
No anaemia | 34 | 70.2 | 64.6 | ||
Adjuvant anaemia | |||||
Anaemia | 98 | 62.2 | 0.73 | 56.6 | 0.66 |
No anaemia | 35 | 62.5 | 51.3 | ||
Hb dynamic change | |||||
Continuous decrease | 58 | 52.3 | 0.04 | 49.6 | 0.23 |
Noncontinuous decrease | 75 | 68.5 | 59.4 | ||
Δ Hb level | |||||
Δ Hb ≤ 7.6 | 33 | 75.8 | 0.04 | 62.9 | 0.31 |
Δ Hb > 7.6 | 100 | 57.5 | 52.6 | ||
Pretreatment anaemia | |||||
Δ Hb ≤ 7.6 | 21 | 77.1 | 0.03 | 62.6 | 0.52 |
Δ Hb > 7.6 | 18 | 46.5 | 52.9 | ||
Pretreatment non-anaemia | |||||
Δ Hb ≤ 7.6 | 12 | 57.7 | 0.91 | 63.6 | 0.53 |
Δ Hb > 7.6 | 82 | 53.1 | 52.5 | ||
Neoadjuvant anaemia | |||||
Δ Hb ≤ 7.6 | 24 | 76.3 | 0.01 | 64.6 | 0.15 |
Δ Hb > 7.6 | 75 | 44.7 | 47.4 | ||
Neoadjuvant non-anaemia | |||||
Δ Hb ≤ 7.6 | 8 | 57.1 | 0.43 | 57.1 | 0.65 |
Δ Hb > 7.6 | 26 | 67.4 | 66.5 | ||
Adjuvant anaemia | |||||
Δ Hb ≤ 7.6 | 17 | 19.5 | 0.02 | 69.3 | 0.24 |
Δ Hb > 7.6 | 81 | 50.1 | 53.4 | ||
Adjuvant non-anaemia | |||||
Δ Hb ≤ 7.6 | 15 | 58.6 | 0.85 | 53.8 | 0.80 |
Δ Hb > 7.6 | 20 | 58.3 | 50.0 | ||